Testing effectiveness (Phase 2)Study completedNCT00196820What this trial is testingMono Efficacy of Capecitabine (MoniCa)Who this might be right forBreast Cancer GBG Forschungs GmbH 200
Testing effectiveness (Phase 2)Ended earlyNCT01272141What this trial is testingLapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast CancerWho this might be right forBreast NeoplasmsBreast CancerCancer of the Breast Emory University 5
Large-scale testing (Phase 3)UnknownNCT02404051What this trial is testingFulvestrant and EVerolimus Plus EXemestane in Metastatic Breast CancerWho this might be right forMetastatic Breast CancerBreast CancerHormone Receptor Positive Tumor+2 more Consorzio Oncotech 745
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06308939What this trial is testingEribulin Combined With Sintilimab as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Breast Cancer:A Multicenter, Single-arm,Phase II Clinical TrialWho this might be right forMetastatic Breast Cancer Zhejiang Cancer Hospital 81
Early research (Phase 1)Study completedNCT03291938What this trial is testingIACS-010759 in Advanced CancersWho this might be right forAdvanced Malignant Solid NeoplasmAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+22 more M.D. Anderson Cancer Center 29
Early research (Phase 1)Looking for participantsNCT06756932What this trial is testingBGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast CancerWho this might be right forHormone-receptor-positive Breast CancerHER2-negative Breast CancerMetastatic Breast Cancer BeOne Medicines 120
Large-scale testing (Phase 3)Active Not RecruitingNCT05132582What this trial is testingTucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast CancerWho this might be right forHER2 Positive Breast Cancer Seagen, a wholly owned subsidiary of Pfizer 654
Testing effectiveness (Phase 2)Ended earlyNCT00959946What this trial is testingStudy Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast CancerWho this might be right forAdvanced Breast Cancer (Parts 1 and 2)Advanced Pancreatic Cancer (Part 1)Advanced Colorectal Cancer (Part 1)+2 more Pfizer 32
Testing effectiveness (Phase 2)Looking for participantsNCT04923542What this trial is testingStereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain MetastasesWho this might be right forBrain MetastasesHR+ Metastatic Breast Cancer H. Lee Moffitt Cancer Center and Research Institute 31
Testing effectiveness (Phase 2)Study completedNCT01276041What this trial is testingPaclitaxel, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast CancerWho this might be right forBreast Cancer Memorial Sloan Kettering Cancer Center 70
Testing effectiveness (Phase 2)Looking for participantsNCT06179303What this trial is testingFunctional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast CancerWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Locally Advanced Unresectable HER2-Negative Breast Carcinoma+3 more University of Washington 60
Testing effectiveness (Phase 2)Study completedNCT02481050What this trial is testingStudy to Evaluate the Efficacy and Safety of Eribulin Mesylate Administered Biweekly (Q2W) for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast CancerWho this might be right forBreast Cancer Eisai Inc. 58
Large-scale testing (Phase 3)UnknownNCT00294996What this trial is testingTrial of Myocet in Metastatic Breast CancerWho this might be right forBreast Cancer Sopherion Therapeutics 363
Testing effectiveness (Phase 2)Active Not RecruitingNCT05323955What this trial is testingSecondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients With aDvanced Human Epidermal Growth Factor Receptor 2+ brEast Cancer With the Addition of TucatinibWho this might be right forBrain MetastasesHuman Epidermal Growth Factor 2 Positive Carcinoma of BreastAdvanced Breast Cancer Carey Anders, M.D. 48
Early research (Phase 1)Study completedNCT01948843What this trial is testingPh 1 ADI-PEG 20 Plus Doxorubicin; Patients With HER2 Negative Metastatic Breast CancerWho this might be right forHER2 Negative Metastatic Breast Cancer Polaris Group 15
Early research (Phase 1)Looking for participantsNCT06784193What this trial is testingPhase 1 Study of OP-3136 in Advanced or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic ER+ HER2- Breast Cancer (mBC)Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC)+3 more Olema Pharmaceuticals, Inc. 180
Large-scale testing (Phase 3)Ended earlyNCT03326674What this trial is testingTesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBCWho this might be right forBreast Cancer Odonate Therapeutics, Inc. 685
Large-scale testing (Phase 3)Study completedNCT02278120What this trial is testingStudy of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast CancerWho this might be right forAdvanced Metastatic Breast Cancer Novartis Pharmaceuticals 672
Early research (Phase 1)Study completedNCT03153163What this trial is testingStudy of the Pharmacokinetics and Safety of Trastuzumab Emtansine in Chinese Participants With Locally Advanced Inoperable or Metastatic HER2+ Breast CancerWho this might be right forBreast Neoplasms Hoffmann-La Roche 11
Testing effectiveness (Phase 2)Ended earlyNCT04791384What this trial is testingPhase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast CancerWho this might be right forBreast Cancer Criterium, Inc. 5